ClinCalc Pro
Menu
Opioid Analgesic (Patient-Controlled Analgesia) Pregnancy: C (D if prolonged use/near delivery)

Morphine PCA (Burns Pain)

Brand names: Morphine Sulphate PCA

Adult dose

Dose: PCA: 1 mg bolus IV with 5-minute lockout; background infusion: 1–2 mg/h (burns); titrate to NRS ≤3
Route: intravenous (PCA device)
Frequency: As demanded by patient (PCA bolus)
Max: 20–30 mg/4h (review if exceeding)
Burns: PCA preferred over PRN nurse-administered for dressing changes and background pain; continuous low-dose background infusion considered in burns >20% TBSA

Paediatric dose

Dose: 0.02 mg/kg
Route: IV
Frequency: PCA bolus every 5–10 min lockout
Max: 0.2 mg/kg/4h
Concentration: 1 mg/mL for PCA (weight-adjusted) mg/ml
Paediatric PCA ≥5 years (able to understand concept): 0.02 mg/kg bolus, 5-10 min lockout; NCA (nurse-controlled analgesia) for younger children

Dose adjustments

Renal

Reduce dose and increase interval if eGFR <30 ml/min (active metabolite accumulation)

Hepatic

Reduce dose in severe hepatic impairment

Paediatric weight-based calculator

Paediatric PCA ≥5 years (able to understand concept): 0.02 mg/kg bolus, 5-10 min lockout; NCA (nurse-controlled analgesia) for younger children

Clinical pearls

  • PCA advantage in burns: patient autonomy reduces anxiety; titrates to individual need; lower total opioid dose vs. PRN
  • Opioid tolerance common in burns due to prolonged opioid exposure — dose escalation often needed; consider opioid rotation
  • PAEDIATRIC DOSE SAFETY: PCA bolus is 0.02 mg/kg once per demand — NOT mg/kg/kg

Contraindications

  • Respiratory depression
  • Raised ICP
  • Concurrent MAOIs
  • Inability to operate PCA device (use NCA)

Side effects

  • Respiratory depression
  • Sedation
  • Nausea/vomiting
  • Constipation
  • Pruritis
  • Urinary retention
  • Dependence

Interactions

  • Benzodiazepines (respiratory depression — FDA black box warning)
  • CNS depressants
  • MAOIs (serotonin syndrome — 14-day washout)

Monitoring

  • NRS pain scores
  • Sedation score
  • Respiratory rate
  • SpO2
  • Cumulative 4-hourly dose review

Reference: BNFc; BNF 86; BBA pain management guidelines; RCoA PCA standards. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.